The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Testing & Screening Market Research Report 2025
Synopsis
Screening means checking your body for cancer before you have symptoms.
The global Cancer Testing & Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer.
This report aims to provide a comprehensive presentation of the global market for Cancer Testing & Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Testing & Screening.
Report Scope
The Cancer Testing & Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Testing & Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Testing & Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dias Orin
Epigenetics
Techlab
Positive Bioscience
Genextropy
M Genomics
20/20 GeneSystems
AB SCIEX
Abbott Laboratories
Segment by Type
Magnetic Resonance Imaging (MRI)
Human Papillomavirus (HPV) Testing
Colonoscopy
Others
Segment by Application
Lung Cancer
Blood Cancer
Bone Cancer
Gall Bladder Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Testing & Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Screening means checking your body for cancer before you have symptoms.
The global Cancer Testing & Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer.
This report aims to provide a comprehensive presentation of the global market for Cancer Testing & Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Testing & Screening.
Report Scope
The Cancer Testing & Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Testing & Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Testing & Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dias Orin
Epigenetics
Techlab
Positive Bioscience
Genextropy
M Genomics
20/20 GeneSystems
AB SCIEX
Abbott Laboratories
Segment by Type
Magnetic Resonance Imaging (MRI)
Human Papillomavirus (HPV) Testing
Colonoscopy
Others
Segment by Application
Lung Cancer
Blood Cancer
Bone Cancer
Gall Bladder Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Testing & Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Testing & Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Magnetic Resonance Imaging (MRI)
1.2.3 Human Papillomavirus (HPV) Testing
1.2.4 Colonoscopy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer Testing & Screening Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Lung Cancer
1.3.3 Blood Cancer
1.3.4 Bone Cancer
1.3.5 Gall Bladder Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Testing & Screening Market Perspective (2019-2030)
2.2 Cancer Testing & Screening Growth Trends by Region
2.2.1 Global Cancer Testing & Screening Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Testing & Screening Historic Market Size by Region (2019-2024)
2.2.3 Cancer Testing & Screening Forecasted Market Size by Region (2025-2030)
2.3 Cancer Testing & Screening Market Dynamics
2.3.1 Cancer Testing & Screening Industry Trends
2.3.2 Cancer Testing & Screening Market Drivers
2.3.3 Cancer Testing & Screening Market Challenges
2.3.4 Cancer Testing & Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Testing & Screening Players by Revenue
3.1.1 Global Top Cancer Testing & Screening Players by Revenue (2019-2024)
3.1.2 Global Cancer Testing & Screening Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Testing & Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Testing & Screening Revenue
3.4 Global Cancer Testing & Screening Market Concentration Ratio
3.4.1 Global Cancer Testing & Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Testing & Screening Revenue in 2023
3.5 Cancer Testing & Screening Key Players Head office and Area Served
3.6 Key Players Cancer Testing & Screening Product Solution and Service
3.7 Date of Enter into Cancer Testing & Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Testing & Screening Breakdown Data by Type
4.1 Global Cancer Testing & Screening Historic Market Size by Type (2019-2024)
4.2 Global Cancer Testing & Screening Forecasted Market Size by Type (2025-2030)
5 Cancer Testing & Screening Breakdown Data by Application
5.1 Global Cancer Testing & Screening Historic Market Size by Application (2019-2024)
5.2 Global Cancer Testing & Screening Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Testing & Screening Market Size (2019-2030)
6.2 North America Cancer Testing & Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Testing & Screening Market Size by Country (2019-2024)
6.4 North America Cancer Testing & Screening Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Testing & Screening Market Size (2019-2030)
7.2 Europe Cancer Testing & Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Testing & Screening Market Size by Country (2019-2024)
7.4 Europe Cancer Testing & Screening Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Testing & Screening Market Size (2019-2030)
8.2 Asia-Pacific Cancer Testing & Screening Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Testing & Screening Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Testing & Screening Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Testing & Screening Market Size (2019-2030)
9.2 Latin America Cancer Testing & Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Testing & Screening Market Size by Country (2019-2024)
9.4 Latin America Cancer Testing & Screening Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Testing & Screening Market Size (2019-2030)
10.2 Middle East & Africa Cancer Testing & Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Testing & Screening Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Testing & Screening Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dias Orin
11.1.1 Dias Orin Company Detail
11.1.2 Dias Orin Business Overview
11.1.3 Dias Orin Cancer Testing & Screening Introduction
11.1.4 Dias Orin Revenue in Cancer Testing & Screening Business (2019-2024)
11.1.5 Dias Orin Recent Development
11.2 Epigenetics
11.2.1 Epigenetics Company Detail
11.2.2 Epigenetics Business Overview
11.2.3 Epigenetics Cancer Testing & Screening Introduction
11.2.4 Epigenetics Revenue in Cancer Testing & Screening Business (2019-2024)
11.2.5 Epigenetics Recent Development
11.3 Techlab
11.3.1 Techlab Company Detail
11.3.2 Techlab Business Overview
11.3.3 Techlab Cancer Testing & Screening Introduction
11.3.4 Techlab Revenue in Cancer Testing & Screening Business (2019-2024)
11.3.5 Techlab Recent Development
11.4 Positive Bioscience
11.4.1 Positive Bioscience Company Detail
11.4.2 Positive Bioscience Business Overview
11.4.3 Positive Bioscience Cancer Testing & Screening Introduction
11.4.4 Positive Bioscience Revenue in Cancer Testing & Screening Business (2019-2024)
11.4.5 Positive Bioscience Recent Development
11.5 Genextropy
11.5.1 Genextropy Company Detail
11.5.2 Genextropy Business Overview
11.5.3 Genextropy Cancer Testing & Screening Introduction
11.5.4 Genextropy Revenue in Cancer Testing & Screening Business (2019-2024)
11.5.5 Genextropy Recent Development
11.6 M Genomics
11.6.1 M Genomics Company Detail
11.6.2 M Genomics Business Overview
11.6.3 M Genomics Cancer Testing & Screening Introduction
11.6.4 M Genomics Revenue in Cancer Testing & Screening Business (2019-2024)
11.6.5 M Genomics Recent Development
11.7 20/20 GeneSystems
11.7.1 20/20 GeneSystems Company Detail
11.7.2 20/20 GeneSystems Business Overview
11.7.3 20/20 GeneSystems Cancer Testing & Screening Introduction
11.7.4 20/20 GeneSystems Revenue in Cancer Testing & Screening Business (2019-2024)
11.7.5 20/20 GeneSystems Recent Development
11.8 AB SCIEX
11.8.1 AB SCIEX Company Detail
11.8.2 AB SCIEX Business Overview
11.8.3 AB SCIEX Cancer Testing & Screening Introduction
11.8.4 AB SCIEX Revenue in Cancer Testing & Screening Business (2019-2024)
11.8.5 AB SCIEX Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Detail
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Cancer Testing & Screening Introduction
11.9.4 Abbott Laboratories Revenue in Cancer Testing & Screening Business (2019-2024)
11.9.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
